A novel oncostatin M/interleukin-31 receptor mutation in familial primary localized cutaneous amyloidosis by Adams-Smith, Rebecca et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/125844/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Adams-Smith, Rebecca, Colmont, C., Mukhtar, A., Morgan, H. and Patel, G. K. 2020. A novel
oncostatin M/interleukin-31 receptor mutation in familial primary localized cutaneous amyloidosis.
Clinical and Experimental Dermatology 45 (2) , pp. 254-256. 10.1111/ced.14059 file 
Publishers page: http://dx.doi.org/10.1111/ced.14059 <http://dx.doi.org/10.1111/ced.14059>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
1	
	
	
	
A novel Oncostatin M receptor mutation in  
familial primary localised cutaneous amyloidosis 
 
Rebecca Adams1*, Chantal Colmont2*, Abdullahi Mukhtar1, Huw 
Morgan1, Girish Khandubhai Patel1. 
 
(1)  European Cancer Stem Cell Research Institute, Cardiff School of Biosciences, Cardiff 
University, Cardiff, UK (2)  Molecular & Experimental Medicine, Cardiff University School 
of Medicine, Department of Nephrology, Cardiff, UK. 
* denotes joint first author 
Correspondence (proof and reprints request address): 
Dr Girish K Patel 
Honorary Senior Lecturer and Consultant Dermatologist, 
European Cancer Stem Cell Research Institute,  
Cardiff School of Biosciences,  
Cardiff University,  
Cardiff, UK  
Tel: 029 2068 8520 
Email: patelgk@cardiff.ac.uk 
 
	
	
	
Word	Count:	415	
	
Figures:	1	
	
Funding sources: Hywel Dda University Health Board NHS R&D. 
 
Conflicts of interests: None declared.  
2	
	
Primary	localised	cutaneous	amyloidosis	(PLCA)	is	a	chronic	disorder,	characterised	by	small	
flat	 topped	papules	or	brown-grey	macules,	which	are	 intensely	 itchy	
1
.	Underpinning	 the	
clinical	 manifestations	 is	 the	 deposition	 of	 beta-sheets	 of	 extracellular	 protein	 in	 the	
papillary	 dermis,	 thought	 to	 arise	 from	 degenerate	 protein	 from	 basal	 keratinocytes,	
immunoglobulins	and	normal	 serum	amyloid	P	component.	Most	 cases	are	 sporadic,	with	
autosomal	dominant	inheritance	responsible	for	about	10%	of	cases,	and	although	common	
in	South	American	and	Asian	populations	
1-4
,	it	is	rare	amongst	Caucasians.		
	
Mutations	 in	 the	OSMR	 and	 IL31RA	genes	have	been	previously	 reported	 in	patients	with	
PLCA
	1-5
.	The	OSMR	gene	encodes	oncostatin	M	receptor	β	(OSMR-β),	a	member	of	the	IL-6	
type	cytokine	receptor	family	that	binds	 IL-31	and	oncostatin-M	(OSM).	Overexpression	of	
IL-31	in	mice	has	been	shown	to	cause	itchy	dermatitis	and	thought	to	contribute	to	pruritic	
skin	conditions	in	humans,	such	as	nodular	prurigo.	OSM	has	a	role	in	keratinocyte	function,	
mediating	differentiation,	proliferation,	inflammation	and	migration	and	once	bound	to	the	
OSM	 type	 2	 receptor,	 it	 can	 induce	 apoptosis
	 5
.	 The	 exact	 function	 and	 downstream	
signalling	of	OSMR-β,	as	well	as	its	role	in	PLCA,	has	yet	to	be	fully	identified	but	a	reduction	
in	 OSMR-β	 signalling	 could	 explain	 the	 increased	 apoptosis	 of	 basal	 cell	 keratinocytes	
associated	with	PLCA.		
	
A	 35	 year	 old	 Caucasian	 male	 presented	 with	 pruritic	 papules	 on	 his	 lower	 leg	 since	
adolescence	 (Fig.	 1a).	 A	 skin	 biopsy	 of	 a	 lesion,	 from	 the	 patient	 and	 his	 mother,	 both	
demonstrated	extracellular	protein	deposits	were	 seen	 in	 the	papillary	dermis,	which	was	
congo	red	and	thioflavin	T	positive	(Fig.	1b,c).	Written	informed	consent	was	obtained	from	
the	 patient,	 mother	 and	 wife	 for	 a	 genetic	 study.	 	 OSMR	 gene	 sequencing	 identified	 a	
3	
	
heterozygous	single	point	nucleotide	mutation	in	exon	10,	c.1715G>A,	p.R438K	(Fig.	1d),	in	
the	affected	but	not	the	unaffected	individual.	Protein	homology	and	amino	acid	identity	
indicate	 that	 amino	 acids	 p.R438	 is	 	 conserved	 across	 several	 species	 (Fig.	 1e),	 the	
incorporation	 of	 a	 basic	 lysine	 into	 the	 fibronectin	 III	 (FNIII)	 repeat	 of	 the	 extracellular	
component	 of	 the	 OSMR	 would	 alter	 the	 protein	 3D	 structure	 and	 so	 may	 affect	 ligand	
binding.	
	
In	conclusion,	OSMR	mutations	associated	with	PLCA	that	have	been	described	in	the	non-
cytokine	 binding	 FNIII	 repeats	 that	 form	 the	 extracellular	 “hinge”	 beneath	 the	 cytokine	
binding	portion	of	the	protein.	The	novel	mutation	described	herein	resides	in	the	third	such	
non-cytokine	binding	FNIII	(Fig.	1f),	highlighting	the	importance	of	the	hinge	in	modulating	
receptor	ligand	interaction	and	signal	transduction.			
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Figure	Legends	
	
Figure	1.	(a)	Numerous	firm	skin	coloured	papules	on	the	lower	limbs.	Skin	histology	
demonstrated	a	mild	acanthosis,	with	dermal	deposit	which	was	congo	red	positive	(b)	and	
demonstrated	thioflavin	T	stain	fluorescence	(c).	(d)	Electropherogram	of	sequencing	by	
forward	(and	reverse)	primers	identified	a	heterozygous	mutation	c.1715G>A	in	affected	
family	members,	leading	to	a	change	in	amino	acid	p.R438K	at	a	conserved	site	(e),	
representing	a	novel	mutational	site	in	the	predicted	protein	(f).			
	
	
	
